When people ask me about lion's mane benefits, they usually want to know whether this mushroom can improve memory, focus, mood, or sleep. Lion’s mane, scientifically known as Hericium erinaceus, has an interesting biological profile and some encouraging early human research. However, the current evidence does not justify presenting it as a proven cognitive enhancer or treatment for any medical condition.
My goal in this review is to separate what has been observed in small human trials from what remains theoretical. I will focus on healthy adults while also explaining why studies involving mild cognitive impairment or mild Alzheimer’s disease should not be generalized to healthy people.
What Is Lion’s Mane?
Lion’s mane is an edible mushroom with a distinctive white, cascading appearance. Researchers have studied two groups of compounds associated with its potential neurological effects: erinacines and hericenones.
Erinacines are found primarily in the mushroom’s mycelium, while hericenones are associated more commonly with the fruiting body. Laboratory and animal research suggests that some of these compounds may influence nerve growth factor, or NGF, and other pathways involved in neuronal growth and maintenance. A PubMed review of the neurotrophic and neuroprotective effects of Hericium erinaceus describes this biological rationale.
That mechanism is interesting, but it is not the same as proving a benefit in people. A compound that affects a pathway in a laboratory experiment may not reach the same tissue concentrations in humans, and a biological effect does not automatically translate into better memory, mood, or sleep.
The mushroom’s composition also varies by product. A preparation made from fruiting body may not contain the same compounds or concentrations as a mycelium-based extract. Extraction methods, dose, standardization, and product quality can all influence how closely a supplement resembles the preparation used in a clinical trial.
Lion's Mane Benefits and Human Cognition
The most frequently discussed potential benefit is cognition. The human evidence is real but limited, and the results are not consistent enough to support strong claims for healthy adults.
Mori 2008 and Mild Cognitive Impairment
The most often cited clinical trial was a small randomized, double-blind, placebo-controlled study involving 30 adults between ages 50 and 80 who had mild cognitive impairment. Participants took approximately 3 grams per day of powdered lion’s mane for 16 weeks.
The lion’s mane group showed higher scores on the Revised Hasegawa Dementia Scale at several points during the treatment period. However, scores declined after participants stopped taking the mushroom. The study was short, involved only 30 people, and used a single primary cognitive scale. The findings therefore suggest a possible short-term and reversible effect rather than evidence that lion’s mane changes the course of cognitive decline.
You can review the original Mori 2008 mild cognitive impairment trial on PubMed.
This study is important because it provides a human signal, but it does not answer whether lion’s mane improves memory or concentration in healthy adults. People with mild cognitive impairment may also respond differently from people who begin with normal cognitive function.
Saitsu 2019 and MMSE Results
A later study examined adults who consumed a fruiting-body preparation for 12 weeks. The investigators used the Mini-Mental State Examination, the Benton Visual Retention Test, and a verbal paired-associate learning test.
The Mini-Mental State Examination showed an improvement in the lion’s mane group compared with the control group, while the broader results were less uniformly positive. The study was relatively small and short, and the investigators used language suggesting dementia prevention. I would interpret that wording cautiously because the trial was not designed to establish prevention of dementia.
The Saitsu 2019 cognitive trial supports continued research, but it does not establish a reliable benefit for healthy adults.
Docherty 2023 in Healthy Young Adults
The Docherty study is more relevant to healthy adults. It included 41 healthy adults between 18 and 45 years of age and evaluated both an acute dose and 28 days of supplementation.
After a single dose, participants performed faster on a Stroop task 60 minutes later. After 28 days, the researchers observed a trend toward lower subjective stress, but that finding did not meet the conventional threshold for statistical significance.
The authors appropriately described the findings as tentative. The study was a pilot with a small sample, and some results were null or limited. You can read the Docherty 2023 pilot study in healthy young adults.
For me, the main conclusion is that lion’s mane may influence performance on a specific task under specific conditions. That is different from demonstrating broad improvements in memory, intelligence, focus, or daily productivity.
Surendran 2025 and Grozier 2022
The more recent evidence remains mixed. In an acute crossover trial, 18 healthy adults received a standardized fruiting-body extract or placebo. The study found no significant overall improvement in composite cognitive performance or mood. One individual motor-performance task favored lion’s mane, but the investigators emphasized that any effect might be task-specific.
The Surendran 2025 acute trial is useful because it illustrates why isolated positive findings should be interpreted carefully. A single task can improve by chance, through familiarity, or because the supplement affects one narrow domain without producing a meaningful general cognitive change.
The Grozier 2022 study also found no significant effect after four weeks of 10 grams per day in college-age participants. It did not improve the measured cognitive outcomes or metabolic flexibility markers. The Grozier 2022 null trial is an important counterweight to promotional claims.
Taken together, the healthy-adult evidence suggests inconsistent and possibly small task-specific effects. It does not demonstrate a dependable improvement in overall cognition.
What About Mood and Sleep?
Mood and sleep are often included in discussions of lion’s mane benefits, but the evidence is even less established than the cognition research.
The Docherty study found a trend toward reduced subjective stress after 28 days, but the result was preliminary. The Surendran acute study did not find a significant overall mood benefit. Another small four-week study involving female undergraduate students reported improvements in self-reported anxiety, depression, and sleep-disturbance scores. You can review that four-week human study of lion’s mane and mood-related symptoms.
I would not interpret that study as proof that lion’s mane treats anxiety, depression, insomnia, or any other condition. Self-reported scales can be useful, but they are affected by expectations, daily stress, sleep habits, and many other factors. Small studies also tend to produce unstable results that may not be replicated in larger trials.
At this point, a careful summary would be:
- Small studies suggest possible changes in stress, mood-related scores, or sleep disturbance.
- The studies are short and involve limited numbers of participants.
- Results do not establish treatment for depression, anxiety, or sleep disorders.
- More rigorous trials are needed before recommending lion’s mane for mood or sleep.
If sleep quality is your main concern, I would first review sleep duration, bedtime regularity, light exposure, caffeine timing, medications, alcohol use, snoring, and symptoms of sleep apnea. My discussion of circadian rhythm and cortisol levels explains why daily timing and sleep habits deserve attention before relying on a supplement.
What Did the Mild Alzheimer’s Pilot Show?
The Li 2020 study evaluated an erinacine A-enriched mycelium preparation in adults with mild Alzheimer’s disease. The trial lasted 49 weeks and reported differences in several cognitive and functional measurements between the intervention and placebo groups.
This study is notable because it lasted longer than many lion’s mane trials. However, it was still a pilot study with a limited sample, a specific formulation, and a population that cannot be equated with healthy adults. Four participants stopped because of abdominal discomfort, nausea, or skin rash.
The Li 2020 mild Alzheimer’s pilot study does not show that lion’s mane treats Alzheimer’s disease. It does not establish disease modification, prevention, or replacement of standard medical care. At most, it provides a reason for larger, independently replicated trials.
Safety and Practical Cautions
Short-term studies generally describe lion’s mane as reasonably well tolerated, but the long-term safety picture is incomplete. Product quality also varies considerably.
Possible concerns include:
- Gastrointestinal discomfort can occur.
- Skin rash or allergic reactions are possible, particularly in people sensitive to mushrooms.
- Pregnancy, breastfeeding, frailty, and multiple chronic illnesses have not been studied adequately.
- Commercial products may differ substantially from the preparations used in clinical trials.
- Supplements can complicate medication reviews even when they appear natural.
If you choose to try lion’s mane as a healthy adult, look for a product that clearly identifies whether it uses fruiting body, mycelium, or both. Pay attention to serving size and testing information, and avoid assuming that a higher dose is better. Stop if you develop a rash, breathing difficulty, persistent gastrointestinal symptoms, or another concerning reaction.
I would also discuss supplement use with a clinician if you take multiple medications or have a significant medical condition. A supplement should not delay evaluation for new memory problems, persistent low mood, severe anxiety, or chronic insomnia.
My Physician’s Bottom Line
The current research supports curiosity, not certainty. Lion’s mane has biologically plausible compounds, including erinacines and hericenones, and several small human trials have reported limited signals involving cognition, stress, mood, or sleep-related measures.
For healthy adults, however, the evidence remains inconsistent. The 2023 pilot suggested faster performance on one task and a possible stress-related trend. The 2025 acute trial found no overall cognitive or mood improvement. The 2022 trial was negative. These results do not support a broad claim that lion’s mane reliably improves memory, focus, mood, or sleep.
The most responsible summary is that lion’s mane is an interesting supplement under investigation. It is not a proven treatment for Alzheimer’s disease, dementia, depression, anxiety, insomnia, or another medical condition.
Frequently Asked Questions
Can lion’s mane improve memory in healthy adults?
Current human studies do not show a consistent, clinically meaningful memory benefit in healthy adults. Some trials report improvements on individual tasks, while others find no significant cognitive effect. Larger and longer studies are needed.
Do erinacines and hericenones prove that lion’s mane works?
No. Erinacines and hericenones provide biological plausibility because laboratory research suggests they may influence nerve growth factor pathways. That mechanism does not prove that a commercial supplement will improve cognition, mood, or sleep in people.
Is lion’s mane a treatment for Alzheimer’s disease?
No. A small pilot study in people with mild Alzheimer’s disease reported differences in selected cognitive and functional measures, but it did not establish treatment or disease modification. Lion’s mane should not replace standard medical care.
Can lion’s mane help with anxiety or depression?
Small studies have reported changes in self-reported mood-related scores, but the evidence is preliminary. Lion’s mane has not been established as a treatment for anxiety or depression, and persistent symptoms deserve a proper clinical evaluation.
Is lion’s mane safe for long-term use?
Long-term safety has not been adequately established. Short-term studies have generally reported reasonable tolerability, but product quality varies and some participants have experienced gastrointestinal symptoms or rash. Discuss ongoing use with a clinician if you take medications or have chronic health concerns.
William McArthur, MD — Evidence-Based Health Insights